The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherence†

Objective: To compare the Inhaler Compliance AssessmentTM (INCATM), a novel audio-recording device objectively measuring timing and proficiency of inhaler use, against established adherence measures, and explore its discriminant and predictive validity. Design: Prospective observational study; 184 chronic obstructive pulmonary disease (COPD) patients used an INCATM-enabled salmeterol/fluticasone inhaler for one-month post-hospital discharge. Main outcome measures: INCATM (Attempted, Attempted Interval, Actual) adherence correlated with Doses Used Rate, self-reported adherence and prescription refill for concurrent validity. Discriminant validity for reason for admission, cognition and lung function; predictive validity for health status and quality-of-life. Results: Rates of Attempted, Attempted Interval and Actual adherence were 59, 47 and 23%, respectively. Only 7% of participants had Actual adherence >80%. INCATM variables significantly correlated with Doses Used Rate but not with self-report; Attempted and Attempted Interval were weakly associated with prescription refill. Higher cognitive and lung functioning groups had better INCATM adherence. Attempted and Attempted Interval predicted health status, while Doses Used Rate predicted quality-of-life. Conclusion: INCATM did not strongly correlate with self-report or prescription refill data. Discriminant and predictive validity demonstrated by INCATM suggests the potential utility of the INCATM as a method to identify intentional and unintentional adherence to inhaled medication and facilitate targeted intervention.

[1]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[2]  C. Abraham,et al.  The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions , 2013, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[3]  W. Rief,et al.  Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD) , 2016, Psychology & health.

[4]  J A Anderson,et al.  Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.

[5]  A. Farmer,et al.  Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity , 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[6]  Richard B. Reilly,et al.  The Acoustic Features of Inhalation can be Used to Quantify Aerosol Delivery from a Diskus™ Dry Powder Inhaler , 2014, Pharmaceutical Research.

[7]  Richard B. Reilly,et al.  A Method to Assess Adherence in Inhaler Use through Analysis of Acoustic Recordings of Inhaler Events , 2014, PloS one.

[8]  J. Bourbeau,et al.  Patient adherence in COPD , 2008, Thorax.

[9]  M. Dimatteo,et al.  Improving the measurement of self-reported medication nonadherence: response to authors. , 2011, Journal of clinical epidemiology.

[10]  J. Arnsten,et al.  Practical and Conceptual Challenges in Measuring Antiretroviral Adherence , 2006, Journal of acquired immune deficiency syndromes.

[11]  C. Bova,et al.  A Proposal for Quality Standards for Measuring Medication Adherence in Research , 2012, AIDS and Behavior.

[12]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[13]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[14]  Tx Station.  Stata Statistical Software: Release 7. , 2001 .

[15]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[16]  S. van Dulmen,et al.  Patient adherence to medical treatment: a review of reviews , 2007, BMC Health Services Research.

[17]  Richard B Reilly,et al.  A method of estimating inspiratory flow rate and volume from an inhaler using acoustic measurements , 2013, Physiological measurement.

[18]  Richard B. Reilly,et al.  Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease , 2017, American journal of respiratory and critical care medicine.

[19]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[20]  R. Reilly,et al.  Acoustic Analysis of Inhaler Sounds From Community-Dwelling Asthmatic Patients for Automatic Assessment of Adherence , 2014, IEEE Journal of Translational Engineering in Health and Medicine.

[21]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[22]  Paul A. Fishman,et al.  Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model , 2003, Medical care.

[23]  Marie Krousel-Wood,et al.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension. , 2009, The American journal of managed care.

[24]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[25]  Jeff Harrison,et al.  Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians. , 2015, The journal of allergy and clinical immunology. In practice.

[26]  R. Zuwallack,et al.  Why Don't Our Patients with Chronic Obstructive Pulmonary Disease Listen to Us? The Enigma of Nonadherence. , 2016, Annals of the American Thoracic Society.

[27]  J. Bernhardt,et al.  The Montreal Cognitive Assessment: Short Cognitive Evaluation in a Large Stroke Trial , 2011, Stroke.

[28]  Leslie R. Martin,et al.  Improving patient adherence: a three-factor model to guide practice , 2012 .

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[30]  C. H. Wood,et al.  Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population , 1959, British medical journal.

[31]  Paula Fresco,et al.  Medication Adherence Measures: An Overview , 2015, BioMed research international.

[32]  Bradley C Martin,et al.  Good and poor adherence: optimal cut-point for adherence measures using administrative claims data , 2009, Current medical research and opinion.

[33]  L. A. Phillips,et al.  Self-management of chronic illness: the role of ‘habit’ versus reflective factors in exercise and medication adherence , 2016, Journal of Behavioral Medicine.

[34]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[35]  M. Bonini,et al.  The importance of inhaler devices in the treatment of COPD , 2015 .

[36]  D. William Molloy,et al.  Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments , 2016, Journal of Alzheimer's disease : JAD.

[37]  R. Sanson-Fisher,et al.  Improving medication adherence in chronic obstructive pulmonary disease: a systematic review , 2013, Respiratory Research.

[38]  Niels H Chavannes,et al.  Clinical and economic impact of non-adherence in COPD: a systematic review. , 2014, Respiratory medicine.

[39]  Matthew Perri,et al.  Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature , 2013, Drugs & Aging.

[40]  T. Fahey,et al.  Royal College of Surgeons in Ireland , 1900, The Ulster Medical Journal.

[41]  J. Seheult,et al.  Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study , 2014, SpringerPlus.

[42]  T. Lasserson,et al.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[43]  J. Seheult,et al.  Objective Assessment of Adherence to Inhalers by COPD Patients , 2019, Case Medical Research.

[44]  Alain Golay,et al.  Pharmacoeconomic aspects of poor adherence: can better adherence reduce healthcare costs? , 2011, Journal of medical economics.

[45]  M. Davoli,et al.  Use Patterns of Long-acting Bronchodilators in Routine COPD Care: The OUTPUL Study , 2014, COPD.